Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway

Figure 5

Effect of p on histopathology findings. Normal control (a), TAA group (b–d), low dose of pitavastatin-treated groups (e–f), and high dose of the pitavastatin-treated group (g–h).